Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / COM
-
Number of holders
-
94
-
Total 13F shares, excl. options
-
25,669,059
-
Shares change
-
+7,419,726
-
Total reported value, excl. options
-
$189,440,846
-
Value change
-
+$55,764,821
-
Put/Call ratio
-
236%
-
Number of buys
-
65
-
Number of sells
-
-25
-
Price
-
$7.38
Significant Holders of BELLICUM PHARMACEUTICALS INC - COM (BLCM) as of Q2 2018
110 filings reported holding BLCM - BELLICUM PHARMACEUTICALS INC - COM as of Q2 2018.
BELLICUM PHARMACEUTICALS INC - COM (BLCM) has 94 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 25,669,059 shares
.
Largest 10 shareholders include BAKER BROS. ADVISORS LP (4,093,447 shares), JPMORGAN CHASE & CO (3,573,579 shares), BlackRock Inc. (3,112,394 shares), FARALLON CAPITAL MANAGEMENT LLC (2,000,000 shares), VANGUARD GROUP INC (1,924,432 shares), FMR LLC (1,851,555 shares), FRAZIER MANAGEMENT LLC (1,051,441 shares), WASATCH ADVISORS INC (923,824 shares), MILLENNIUM MANAGEMENT LLC (733,850 shares), and STATE STREET CORP (647,709 shares).
This table shows the top 94 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.